The Leukemia & Lymphoma Society Available to Comment on Findings Presented at American Society of Hematology Conference
Published: Dec 06, 2011
WHITE PLAINS, N.Y., Dec. 5, 2011 /PRNewswire/ -- Researchers from around the world will present their findings in blood cancer research at the annual American Society of Hematology (ASH) conference in San DiegoDecember 10-13, 2011.
New discoveries in immunotherapies, blood cancer stem cells, genomics and molecularly targeted therapies will be among the presentations. Throughout the ASH conference, LLS spokespersons John C. Byrd, M.D., The Ohio State University (lymphoid malignancies); Carl H. June, M.D., University of Pennsylvania (immunotherapies); Judith E. Karp, M.D., Johns Hopkins Hospital (acute leukemias in adults); Anna Meadows, M.D., emeritus, Children's Hospital of Philadelphia(pediatric oncology and cancer survivorship); and Robert Z. Orlowski, M.D., Ph.D., MD Anderson Cancer Center, (myeloma), will be available to comment on these and any other research news that emerges from the meeting.
To arrange interviews in advance or during the conference, please contact Andrea Greif at (914) 821-8958 or (914) 772-3027 (cell).
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.
Contact: Andrea Greif
(914) 821-8958, (914) 772-3027 (cell)
SOURCE The Leukemia & Lymphoma Society